Bold Ideas
Backed Early

Through our venture fund and Funding Catalyst service, we fuel innovators across Canada and beyond.

A collection of line art figures, including a briefcase, buildings, a glowing light bulb, a document, and a person next to upwards arrows

Our Portfolio

We have invested in 30 early stage Canadian founders. We raised a $20M sector agnostic fund which is now fully deployed.

Our Investment Team

From our Portfolio

Investments

|

March 12, 2026

NanoTess Secures Deal to Put Its Product in 14,000 Canadian Pharmacies

NanoTess partners with global medical device company to get flagship product NanoSALV in 14,000 Canadian pharmacies.

Investments

|

March 5, 2026

Syantra Featured in BetaKit Ahead of Commercialization of their Onco-ID Breast Cancer Test

Syantra has been featured in BetaKit ahead of the commercialization of their Onco-ID breast cancer screening test this summer. Syantra will also be releasing updated clinical trial data later in Q2.

Investments

|

February 27, 2026

Clinify secures national EMR contract in Nigeria

Clinify secures national EMR contract in Nigeria, positioning Clinify as national infrastructure and attracting further regional demand.

Portfolio Opportunities

Want to invest in any of our portfolio companies?
Reach out at invest@thinairlabs.ca
The companies in our portfolio continually create innovative jobs.